TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia.

Hernan Carol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.